MedTrace Logo

Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®

NCT02354274 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2022-04-25

No results posted yet for this study

Summary

To investigate the effect of escalation of radiation dose to tumor and lymph nodes based on an inhomogeneous dose distribution controlled by FDG-PET positive areas compared to a standard homogeneous dose spread

Conditions

Interventions

RADIATION

Escalated: Inhomogeneous dose plan

RADIATION

Standard: Homogeneous dose plan

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER

  • Aarhus University Hospital

    collaborator OTHER

  • Rigshospitalet, Denmark

    collaborator OTHER

  • Vejle Hospital

    collaborator OTHER

  • Naestved Hospital

    collaborator OTHER

  • Aalborg University Hospital

    collaborator OTHER

  • Herlev Hospital

    collaborator OTHER

  • Olfred Hansen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2029-10-31
Completion
2029-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02354274 on ClinicalTrials.gov